Evidence review and recommendations for the implementation of genomics for antimicrobial resistance surveillance: reports from an international expert group.

Baker, Kate S, Jauneikaite, Elita, Nunn, Jamie G, Midega, Janet T, Atun, Rifat, Holt, Kathryn E, Walia, Kamini, Howden, Benjamin P, Tate, Heather, Okeke, Iruka N, Carattoli, Alessandra, Hsu, Li Yang, Hopkins, Katie L, Muloi, Dishon M, Wheeler, Nicole E, Aanensen, David M, Mason, Lewis C E, Rodgus, Jonah, Hendriksen, Rene S, Essack, Sabiha Y, Egyir, Beverly, Halpin, Alison L, MacCannell, Duncan R, Campos, Josefina, Srikantiah, Padmini, Feasey, Nicholas ORCID: https://orcid.org/0000-0003-4041-1405 and Peacock, Sharon J (2023) 'Evidence review and recommendations for the implementation of genomics for antimicrobial resistance surveillance: reports from an international expert group.'. Lancet Microbe, Vol 4, Issue 12, e1035-e1039.

Preview

Text 1-s2.0-S2666524723002811-main.pdf - Published Version Available under License Creative Commons Attribution. Download (1MB) | Preview

Abstract

Nearly a century after the beginning of the antibiotic era, which has been associated with unparalleled improvements in human health and reductions in mortality associated with infection, the dwindling pipeline for new antibiotic classes coupled with the inevitable spread of antimicrobial resistance (AMR) poses a major global challenge. Historically, surveillance of bacteria with AMR typically relied on phenotypic analysis of isolates taken from infected individuals, which provides only a low-resolution view of the epidemiology behind an individual infection or wider outbreak. Recent years have seen increasing adoption of powerful new genomic technologies with the potential to revolutionise AMR surveillance by providing a high-resolution picture of the AMR profile of the bacteria causing infections and providing real-time actionable information for treating and preventing infection. However, many barriers remain to be overcome before genomic technologies can be adopted as a standard part of routine AMR surveillance around the world. Accordingly, the Surveillance and Epidemiology of Drug-resistant Infections Consortium convened an expert working group to assess the benefits and challenges of using genomics for AMR surveillance. In this Series, we detail these discussions and provide recommendations from the working group that can help to realise the massive potential benefits for genomics in surveillance of AMR.

Item Type:	Article
Corporate Authors:	SEDRIC Genomics Surveillance Working Group
Subjects:	QU Biochemistry > Genetics > QU 460 Genomics. Proteomics QW Microbiology and Immunology > QW 45 Microbial drug resistance. General or not elsewhere classified.
Faculty: Department:	Clinical Sciences & International Health > Clinical Sciences Department
Digital Object Identifer (DOI):	https://doi.org/10.1016/S2666-5247(23)00281-1
SWORD Depositor:	JISC Pubrouter
Depositing User:	JISC Pubrouter
Date Deposited:	10 Jan 2024 13:49
Last Modified:	10 Jan 2024 13:49
URI:	https://archive.lstmed.ac.uk/id/eprint/23599

Statistics

View details

Actions (login required)

Edit Item